(Health-NewsWire.Net, July 27, 2017 ) Publisher's clinical trial report "Cardiometabolic Disease Global Clinical Trials Review H1 2017" provides an overview of Cardiometabolic Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Cardiometabolic Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region country (G7 & E7) phase trial status end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials) . Publisher Clinical Trial Reports are generated using Publisher's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries conferences journals news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
- The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region Country (G7 & E7) Trial Status Trial Phase Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title Phase and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global regional and country level
Table of Content List of Tables 3 List of Figures 4 Report Guidance 5 Publisher Clinical Trials Report Coverage 6 Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8 Top Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Clinical Trials by G7 Countries Proportion of Cardiometabolic Disease to Metabolic Disorders Clinical Trials 13 Clinical Trials by Phase in G7 Countries 14 Clinical Trials in G7 Countries by Trial Status 15 Clinical Trials by Phase 16 In Progress Trials by Phase 17 Clinical Trials by Trial Status 18 Clinical Trials by End Point Status 19 Subjects Recruited Over a Period of Time 20 Clinical Trials by Sponsor Type 21 Prominent Sponsors 22 Top Companies Participating in Cardiometabolic Disease Therapeutics Clinical Trials 23 Prominent Drugs 24 Clinical Trial Profile Snapshots 25 Appendix 38 Abbreviations 38 Definitions 38 Research Methodology 39 Secondary Research 39 About Publisher 40 Contact Us 40 Source 40 Inquire for Report at http://www.reportsweb.com/inquiry&RW0001881613/buying